MBX Biosciences Stock Explodes on Promising Phase 2 Data for Once-Weekly Hypoparathyroidism Treatment
Listen up, folks—it's mornings like this that make you glad you rolled out of bed early and cracked open the market feeds. As of this writing, MBX Biosciences ($MBX) is lighting up the tape with a pre-market surge that's north of 120%, turning heads from sleepy...




